Thursday, 25 April 2024
Atara Biotherapeutics Inc.
NASDAQ : ATRA
3.730 14 Oct 22 00:00 | Change: 0.26 | Open: 4.140 | High: 4.160 | Ask: 0.000 | Volume: 785,100 |
Change(%): 6.52 | Prev: 3.990 | Low: 3.690 | Bid: 0.000 | Avg vol: 0 |
04:22 | 17/3/18
Alpha Beta Stock
Canada's main stock index closed higher Thursday while the Canadian dollar dropped for the third day in a row. The S&P/TSX composite index closed up 17.01 points to 15,670.62, led by financials and energy stocks.
more»
02:52 | 17/3/18
Nasdaq Chronicle
Atara Biotherapeutics, Inc. (ATRA) stock price recent trade pushed it move about -16.03% away from the 52-week high and closed 255.08% away from the 52-week low.
more»
01:00 | 17/3/18
GlobeNewswire
SOUTH SAN FRANCISCO, Calif., March 16, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, today ...
more»
23:41 | 14/3/18
Wall Street Morning
Technical analysis of Atara Biotherapeutics, Inc. (ATRA) stock includes the study of technical indicators and past trends.
more»
14:18 | 14/3/18
Simply Wall St
In December 2017, Atara Biotherapeutics Inc (NASDAQ:ATRA) released its latest earnings announcement, which suggested that losses became smaller relative to the prrior year's level - great news for investors Below, I've laid out key numbers on how ...
more»
There are currently no comments on this topic.
Be the first person to Add a Comment...
You must be a registered user to post a comment: REGISTER NOW
If you are already registered, please LOGIN NOW
|
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |